David B. Elsbree - 04 Nov 2024 Form 4 Insider Report for T2 Biosystems, Inc. (TTOO)

Reporting relationship: Director
Issuer ticker: TTOO
Reported as of: 04 Nov 2024
Net transaction value: $0
SEC form: 4
Accepted by SEC: 02 Jan 2025, 18:11:59 UTC
Prior SEC filing: 17 Sep 2024
Source filing: View source filing
Reporting owner signature: /s/ John Sprague, Attorney-in-fact

Key filing fact

David B. Elsbree filed Form 4 for T2 Biosystems, Inc. (TTOO) on 02 Jan 2025.

Key facts

This page summarizes David B. Elsbree's Form 4 filing for T2 Biosystems, Inc. (TTOO).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 Jan 2025, 18:11.

Change

Previous filing in this sequence was filed on 17 Sep 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

TTOO transaction Derivative

Restricted Stock Units

Award

Transaction value: $0
Shares: +25,000
Change %
Price: $0.000000
Shares after: 25,000
Date: 04 Nov 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 25,000
Exercise price
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

Footnote F2

On November 4, 2024, the reporting person was granted 25,000 RSU's that vest in two equal annual installments beginning on November 4, 2025. This grant was contingent on stockholder approval of the amendment and restatement of Issuer's 2014 Incentive Award Plan. The Issuer's stockholders approved the amendment and restatement of the plan on December 30, 2024.